Jatenergy Lactoferrin Surges Unprecedently Due to Coronavirus

  • Feb 03, 2020 AEDT
  • Team Kalkine

Jatenergy Limited (ASX:JAT) notifies about the increased sales of Lactoferrin in China due to the coronavirus.

  • Since December 2019, JAT has seen unprecedented demand in China for its Neurio ranges of dairy products which contain lactoferrin; as,
  • Lactoferrin plays an important role in modulating the immune system, both systemically and in the gastrointestinal tract, by binding with iron, which serves as an important nutrient for pathogens to replicate or grow.
  • January 2020 sales amounted to $3.44 million ($407,000 in January 2019), while orders so far for February 2020 are $2 million (February 2019: $1,099,917) and March 2020 are $1.8 million (March 2019: $388,714).

 

 

All pictures are copyright to their respective owner(s).Kalkinemedia.com does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.

 

There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

CLICK HERE FOR YOUR FREE REPORT!
   
x
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK